The evidence for a protective role of omega
3 fatty acids in CHD is becoming clearer and firmer,
especially for secondary prevention. Intakes of
approximately 800-1,000 mg per day appear to be a prudent
approach for the latter group of patients. The safety of
intakes of up to 3,000 mg per day has been endorsed by the
recent ruling of the FDA that this level of EPA+DHA (from
menhaden oil) is generally recognized as safe (GRAS) for
inclusion in the American food supply. Recommendations
for primary prevention of CHD and for use in other
conditions (inflammatory diseases, autoimmune conditions,
cancer prevention, etc.) cannot yet be made as the requisite
data to support such recommendations is not yet available.
Harris, W.S. Omega-3 Polyunsaturated Fatty Acids and Coronary Heart Disease Prevention. In: Microbehavior and Macroresults:Proceedings of the Tenth Biennial Conference of the International Institute ofFisheries Economics and Trade, July 10-14, 2000, Corvallis, Oregon, USA.Compiled by Richard S. Johnston and Ann L. Shriver. InternationalInstitute of Fisheries Economics and Trade (IIFET), Corvallis, 2001.